Public Health Responses to COVID-19 Outbreaks on Cruise Ships - Worldwide, February-March 2020.

This report describes public health responses to COVID-19 outbreaks on these ships. COVID-19 on cruise ships poses a risk for rapid spread of disease, causing outbreaks in a vulnerable population, and aggressive efforts are required to contain spread. All persons should defer all cruise travel worldwide during the COVID-19 pandemic. PMID: 32214086 [PubMed - in process]
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Tags: MMWR Morb Mortal Wkly Rep Source Type: research

Related Links:

AbstractThe ongoing spread of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a significant threat to global health. As the coronavirus outbreak began spreading, hospitals were forced to relocate resources to treat the growing number of COVID-19 patients. As a consequence, doctors across the country canceled tens of thousands of nonurgent surgeries. However, recognizing that the COVID-19 situation may be highly variable and fluid in different communities across the country, elective surgery could be still allowed in some centers for patients included in t...
Source: Endocrine - Category: Endocrinology Source Type: research
Authors: Machado-Curbelo C Abstract The main characteristics and challenging symptoms of COVID-19, caused by the novel coronavirus SARS-CoV-2, are related to re-spiratory distress. Although most patients have mild symptoms such as fever, headache, cough, myalgia and anosmia, some develop acute respiratory distress syndrome, leading to death in many cases. Human coronavirus (CoVs) were responsible for two previ-ous worldwide outbreaks: Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV). Several reports of these outbreaks demonstrated that these diseases affected the central ...
Source: MEDICC Review - Category: International Medicine & Public Health Tags: MEDICC Rev Source Type: research
We present five teriflunomide-treated patients with MS who subsequently developed active COVID-19 infection. The patients continued teriflunomide therapy and had self-limiting infection, without relapse of their MS. These observations have implications for the management of MS in the setting of the COVID-19 pandemic.
Source: Journal of Neurology - Category: Neurology Source Type: research
ConclusionThe SARS-CoV-2 pandemic and concomitant social restrictions are associated with reduced cardiac events admissions to our tertiary care center. From a public health perspective, strategies have to be developed to assure patients are seeking and getting medical care and treatment in time during SARS-CoV-2 pandemic.
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
Vidya M Mahalmani, Dhruv Mahendru, Ankita Semwal, Sukhmeet Kaur, Harpinder Kaur, Phulen Sarma, Ajay Prakash, Bikash MedhiIndian Journal of Pharmacology 2020 52(2):117-129 In December 2019, severe acute respiratory syndrome-coronavirus-2, a novel coronavirus, initiated an outbreak of pneumonia from Wuhan in China, which rapidly spread worldwide. The clinical characteristics of the disease range from asymptomatic cases or mild symptoms, which include nonspecific symptoms such as fever, cough, sore throat, headache, and nasal congestion to severe cases such as pneumonia, respiratory failure demanding mechanical ventilation t...
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research
In December 2019, reports of viral pneumonia came out of Wuhan city in Hubei province in China. In early 2020, the causative agent was identified as a novel coronavirus (CoV) sharing some sequence similarity with SARS-CoV that caused the severe acute respiratory syndrome outbreak in 2002. The new virus, named SARS-CoV-2, is highly contagious and spread rapidly across the globe causing a pandemic of what became known as coronavirus infectious disease 2019 (COVID-19). Early observations indicated that cardiovascular disease (CVD) patients are at higher risk of progression to severe respiratory manifestations of COVID-19 incl...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven options for prophylaxis for those who have been exposed to SARS–CoV-2, nor therapy for those who develop COVID-19. Immune (i.e., “convalescent”) plasma refers to plasma that is collected from individuals following resolution of infection and development of antibodies. Passive antibody administration through transfusion of convalescent plasma may offer the only short-term strategy for conferring immediate immunity to susceptib...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
The recent outbreak of the coronavirus SARS-COV-2 has led to a worldwide pandemic (Cucinotta and Vanelli, 2020) with substantial social, health and economic costs (UN News, 2020). The epidemic spread quickly from Wuhan to the neighbouring cities and then to the rest of China (Wu et al., 2020), possibly exacerbated by the ‘travel rush’ for the Lunar New Year. On 23rd January 2020, the Chinese government initiated an unprecedented move of introducing a ‘metropolitan-wide quarantine’ of the city of Wuhan, by terminating all public transportation in the city and intercity links (Chen et al., 2020, Zhang Lei et a l., 2020).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
The outbreak of COVID-19 from Wuhan China had been officially characterized as a pandemic on 11th March, 2020 (World Health Organization, 2020b), which has led to more than 3.5 million subjected infected and 0.24 million dead worldwide as of May 4th 2020 (World Health Organization, 2020a). The causative pathogen of COVID-19 has been confirmed as the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) (Lu et al., 2020), which belongs to the coronavirus family and previously caused severe acute respiratory syndrome (SARS) (Peiris et al., 2004) and the Middle East respiratory syndrome (MERS) (Zaki et al., 2012).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
Report’s authors claim the US needs to be testing 20-million people per day in order to achieve ‘full pandemic resilience’ by August Medical laboratory scientists and clinical laboratory leaders know that the US’ inability to provide widespread diagnostic testing to detect SARS-CoV-2—the novel coronavirus that causes the COVID-19 illness—in the early stages of the outbreak […]
Source: Dark Daily - Category: Laboratory Medicine Authors: Tags: Laboratory Hiring & Human Resources Laboratory Management and Operations Laboratory News Laboratory Pathology anatomic pathology Anne-Marie Slaughter Ashish Jha MPH CDC centers for disease control and prevention clinical laboratory cli Source Type: news
More News: China Health | Coronavirus | COVID-19 | Epidemiology | International Medicine & Public Health | Laboratory Medicine | Outbreaks | Pandemics | Respiratory Medicine | SARS